ORAL MANIFESTATIONS OF AUTOIMMUNE DISEASES: DIAGNOSTIC VALUE AND INTERDISCIPLINARY CONSIDERATIONS
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5088Keywords:
Autoimmune Illnesses, Oral Symptoms, Early Diagnosis, Interdisciplinary Treatment, Oral Mucosal Pathology, Systemic InflammationAbstract
Autoimmune diseases comprise a heterogeneous group of chronic inflammatory disorders characterized by dysregulation of innate and adaptive immune responses, leading to tissue damage and progressive multisystem involvement. Early diagnosis remains challenging because these conditions often develop gradually and initially present with nonspecific systemic symptoms. The oral cavity represents an important yet frequently underrecognized diagnostic site due to its unique immunological environment, including rapid epithelial turnover, rich vascularization, constant antigen exposure, and complex microbiota.
In many patients, early autoimmune activity manifests first as oral mucosal lesions, salivary gland dysfunction, gingival abnormalities, or characteristic inflammatory patterns before more typical systemic signs appear. This review summarizes the oral manifestations associated with major autoimmune diseases, including Sjögren’s syndrome, systemic lupus erythematosus, oral lichen planus, pemphigus vulgaris, mucous membrane pemphigoid, inflammatory bowel disease, systemic sclerosis, psoriasis, and celiac disease, and discusses their immunopathological basis.
The paper highlights the critical role of dental professionals in early detection and emphasizes the importance of interdisciplinary collaboration among dentists and medical specialists. Strengthened medical–dental cooperation may improve diagnostic accuracy, reduce delays in treatment initiation, and contribute to better overall patient outcomes.
References
Buckner, J. H. (2010). Mechanisms of impaired regulation by CD4⁺CD25⁺FoxP3⁺ regulatory T cells in human autoimmune diseases. Nature Reviews Immunology, 10(12), 849–859. https://doi.org/10.1038/nri2889
Cooper, G. S., Bynum, M. L., & Somers, E. C. (2009). Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity, 33(3–4), 197–207. https://doi.org/10.1016/j.jaut.2009.09.008
Gianchecchi, E., & Fierabracci, A. (2018). Inhibitory receptors and pathways of lymphocytes: The role of PD-1 in Treg development and their involvement in autoimmunity onset and cancer progression. Frontiers in Immunology, 9, Article 2374. https://doi.org/10.3389/fimmu.2018.02374
Ismail, S. B., Kumar, S. K. S., & Zain, R. B. (2007). Oral lichen planus and lichenoid reactions: Etiopathogenesis, diagnosis, management and malignant transformation. Journal of Oral Science, 49(2), 89–106. https://doi.org/10.2334/josnusd.49.89
Rose, N. R., & Mackay, I. R. (2014). The autoimmune diseases (5th ed.). Academic Press.
Scully, C., & Challacombe, S. J. (2002). Pemphigus vulgaris: Update on etiopathogenesis, oral manifestations, and management. Critical Reviews in Oral Biology & Medicine, 13(5), 397–408. https://doi.org/10.1177/154411130201300504
Shiboski, C. H., Shiboski, S. C., Seror, R., Criswell, L. A., Labetoulle, M., Lietman, T., & International Sjögren’s Syndrome Criteria Working Group. (2017). 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome. Annals of the Rheumatic Diseases, 76(1), 9–16. https://doi.org/10.1136/annrheumdis-2016-210571
Tsokos, G. C. (2011). Systemic lupus erythematosus. The New England Journal of Medicine, 365(22), 2110–2121. https://doi.org/10.1056/NEJMra1100359
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Paulina Giza, Agnieszka Giza, Urszula Marzec, Aleksandra Cyrkler , Natalia Cieślak, Karol Dąbek, Eliza Rajca, Karolina Wymoczył, Agata Chodkowska, Kamila Czyżak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
